PPT-Improving Access for Quality-Assured TB Medicines and Diagnostics

Dr Kaspars Lunte Team Leader Sourcing and Special Projects GDF Copenhagen IPC Meeting 18 June 2015 Update on GDF Procurement Change of the hosting agreement from WHO to UNOPS as from January 1 2015. Medicines Benefits – . Goals, Policy Options, Ethical Considerations. Anita Katharina Wagner. Department of Population Medicine. Harvard Medical School & Harvard Pilgrim Health Care Institute. Cape Town, 29 September 2014. Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Diagnostics, Therapeutics & Central Operations. Meeting the 7 Day . Diagnostic. Access . Challenge. Diagnostics & Therapeutics Group . Diana Princess of Wales. General Radiology. CT/MR. Ultrasound + community locations. Cochin University of Science & Technology . Sakthivel. . Selvaraj. Public Health Foundation of India . New . Delhi . (shakti@phfi.org). Access to Medicines in India . Key Barriers to . Access to Medicines . for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . Gilles . Forte. Coordinator, Policy, Access and Use Team. Essential . Medicines . and . Health Products. . WHO . mandate . within the . International . Drug Control Conventions. 1961 . Single Convention on Narcotic Drugs (Article 3). Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. better access, better outcomes, better value. Fatima Kyari. Nkosi . Agwadu. David . Ejeba. Focus. A balanced approach to . outcome. s, . output. and . outlay. – together with strong partnerships.